DelveInsight has launched a new report on “Rett Syndrome – Market Insights, Epidemiology, and Market Forecast-2030”.
DelveInsight’s “Rett Syndrome – Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the Rett Syndrome, historical and forecasted epidemiology as well as the Rett Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some of the key facts of the Rett Syndrome Market Report:
- According to a study entitled “Development of consensus-based guidelines for managing communication of individuals with Rett syndrome” by Townend et al., stated that Rett syndrome is a neurological disorder known to occur in approximately 1 in 10,000 females and more rarely in males.
- As per a study conducted by M. Itoh et al., which is titled “Epidemiological study of Japanese Rett syndrome”, the prevalence of Rett Syndrome in Japan is approximately 0.90 per 10,000 girls.
- As per a study conducted by the Health Programme of the European Union, the estimated prevalence of Rett Syndrome in Europe is 10.0 per 100,000 and the estimated birth prevalence of Rett Syndrome is 5.0 in 100,000.
- Pini et al. conducted a study titled “Rett syndrome: a wide clinical and autonomic picture” which stated that rett Syndrome is a neurodevelopmental disorder almost exclusively affecting females, characterized by a broad clinical spectrum of signs and symptoms and a peculiar course during life. It occurs with an average frequency of about 1:10,000 in girls.
Key benefits of the report:
- The Rett Syndrome market report covers a descriptive overview and comprehensive insight of the Rett Syndrome Epidemiology and Rett Syndrome market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
- The Rett Syndrome market report provides insights on the current and emerging therapies.
- Rett Syndrome market report provides a global historical and forecasted market covering drug outreach in 7MM.
- The Rett Syndrome market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Rett Syndrome market.
Got queries? Click here to know more about the Rett Syndrome Market Landscape.
Rett Syndrome Overview
Rett syndrome is a unique neurodevelopmental disorder that is first noticed in infancy and primarily affects girls but can be rarely seen in boys. It is caused by mutations on the X-chromosome on a gene called MECP2. There are more than 200 different mutations found in the MECP2 gene. Most of these mutations are found in eight different “hot spots.” Rett syndrome is mostly misdiagnosed as autism, cerebral palsy, or global developmental delay. It is found in all ethnic and racial groups.
Rett syndrome is not a degenerative disorder but causes problems in brain function that are responsible for cognitive, sensory, emotional, motor, and autonomic functions. These can include learning, speech, sensory sensations, mood, movement, breathing, cardiac function, and even chewing, swallowing, and digestion.
Rett Syndrome Market
The dynamics of the Rett Syndrome market are anticipated to change in the coming years owing to the expected launch of emerging therapies such as Acadia Pharmaceuticals/Neuren Pharmaceuticals, GW Research, and others during the forecasted period 2018-2030.
Rett Syndrome Pipeline Therapies and Key Companies
- NNZ-2566 (Trofinetide): Acadia Pharmaceuticals/Neuren Pharmaceuticals
- GWP42003-P (Epidiolex): GW Research
Table of Contents
1. Report Introduction
2. Executive Summary
3. SWOT analysis
4. Rett Syndrome Patient Share (%) Overview at a Glance
5. Rett Syndrome Market Overview at a Glance
6. Rett Syndrome Disease Background and Overview
7. Rett Syndrome Epidemiology and Patient Population
8. Country-Specific Patient Population of Rett Syndrome
9. Rett Syndrome Current Treatment and Medical Practices
10. Unmet Needs
11. Rett Syndrome Emerging Therapies
12. Rett Syndrome Market Outlook
13. Country-Wise Rett Syndrome Market Analysis (2018–2030)
14. Market Access and Reimbursement of Therapies
15. Market drivers
16. Market barriers
17. Appendix
18. Rett Syndrome Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Click here to read more about Rett Syndrome Market Outlook 2030.
Related Reports:
Rett Syndrome Pipeline
Rett Syndrome Epidemiology
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/